References
- Misiewicz J J, Bradbury J E. Review of trials of maintenance treatment for the prevention of duodenal ulcer recurrence. Ranitidine therapeutic advances, J J Misiewicz, J R Wood. Excerpta Medica, Amsterdam 1984; 43–88
- Guslandi M, Masci E, Testoni P A, Ballarin E. Comparison of cimetidine and ranitidine in long-term treatment of duodenal ulcer. Clin Trials J 1983; 20: 67–70
- Gough K R, Korman M G, Bardhan K D, Lee F I, Crowe J P, Reed P I. Ranitidine and cimetidine in prevention of duodenal ulcer relapse. Lancet 1984; ii: 659–662
- Bytzer P, Lauritsen K, Rask-Madsen J. Symptomatic recurrence of healed duodenal and prepyloric ulcers after treatment with ranitidine or high-dose antacid. A 1-year follow-up study. Scand J Gastroenterol 1986; 21: 765–768
- Charlet N, Gallo-Torres H E, Bounameaux Y, Wills R J. Prostaglandins and the protection of the gastro-duodenal mucose in humans: a critical review. J Clin Pharmacol 1985; 25: 564–582
- Collins P W. Development and therapeutic role of synthetic prostaglandins in peptic ulcer disease. J Med Chem 1986; 29: 437–443
- Miller T A. Protective effects of prostaglandins against mucosal damage: current knowledge and proposed mechanisms. Am J Physiol 1983; 245: G601–G623
- Hawkey C J, Rampton D S. Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment?. Gastroenterology 1985; 89: 1162–1188
- Quadros E, Ramsamooj E, Rajapaksa T, Wilson D E. Cytoprotective effects of a prostaglandin E, (PGE1) analogue: relationship to mucus synthesis and release in man and the rat. Gastroenterology 1984; 86: 1214
- Singer M V, Schulte H, Demol P, Eysselein V, Goebell H. Dose response effects of rioprostil, a new synthetic methyl prostaglandin E, on gastric-acid secretion and release of gastrin in humans. Gastroenterology 1985; 88: 1588
- Rajapaksa T, Adams A, Ramsamooj E, Quadros E, Wilson D E. The effects of an oral prostaglandin E1 (PGE) analogue on gastric acid and mucus secretion in man. Clin Res 1983; 31: 766A
- Boucekkine T, Meknini B, Bitoun A, Bernier J J. Treatment of duodenal-ulcer–comparison rioprostil versus placebo. Gastroenterology 1985; 88: 1332
- Dammann H G, Walter Th A, Mullier P, Simon B. Rioprostil 600 μg nocte: high duodenal ulcer healing rates, low incidence of side effects. Gastroenterology 1986; 90: 1386
- Simon B, Dammann H-G, Müller P. Prostaglandins and peptic ulcer disease: nocturnal administration of rioprostil vs raniditine in duodenal ulcer healing. Klin Wochenschr 1986; 64(Suppl 7)44–46
- Rampal P, Raillat A, Slama J L, et al. Duodenal ulcer healing. Rioprostil versus ranitidine. Gastroenterology 1986; 90: 1597
- Dammann H G, Rehner M, Walter T A, Miiller P, Simon B Z. Effects of rioprostil on the 24 hour intragastric acid concentration. Z Gastroenterol 1986; 24: 245–249
- Howden C W. Rioprostil and duodenal ulcer. Lancet 1986; ii: 686
- Lauritsen K, Havelund T, Laursen L S, Bytzer P, Kjaergaard J, Rask-Madsen J. Enprostil and ranitidine in prevention of duodenal ulcer relapse: one year double blind comparative trial. Br Med J 1987; 294: 932–934